Skip to main content

Table 1 Demographic and clinical characteristics of the 2 patient groups

From: Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment

  All Teriparatide-treated Non-Teriparatide-treated p-value
Atypical fracture 16 8 8  
Age (yr) 70.15 70.25(68) 69.25(72.5) 0.916
Duration of Bisphosphonate use (yr) 4.04 4.36 (5) 4 (4) 0.696
Proximal femur fracture 6 3 3 1
Subtrochanteric fracture 10 5 5 1
Time to union (month) 5.3 4.4 (4) 6.2 (5.6) 0.093
Union at 6 months (%) 10 (62.5%) 6 (75%) 4 (50%) 0.608
Implant failure 1 0 1 1
  1. Data presented as mean (median)